These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


136 related items for PubMed ID: 6149246

  • 1. Treatment of disseminated leukemia with cyclophosphamide and immune cells: tumor immunity reflects long-term persistence of tumor-specific donor T cells.
    Greenberg PD, Cheever MA.
    J Immunol; 1984 Dec; 133(6):3401-7. PubMed ID: 6149246
    [Abstract] [Full Text] [Related]

  • 2. Donor T cells can be induced to grow and survive long term in vivo without previous host immunosuppression.
    Chen W, Cheever MA.
    J Immunol; 1994 May 15; 152(10):4767-74. PubMed ID: 8176202
    [Abstract] [Full Text] [Related]

  • 3. Therapy of murine leukemia with cyclophosphamide and immune Lyt-2+ cells: cytolytic T cells can mediate eradication of disseminated leukemia.
    Greenberg PD.
    J Immunol; 1986 Mar 01; 136(5):1917-22. PubMed ID: 3485134
    [Abstract] [Full Text] [Related]

  • 4. Adoptively transferred antigen-specific T cells can be grown and maintained in large numbers in vivo for extended periods of time by intermittent restimulation with specific antigen plus IL-2.
    Chen W, Reese VA, Cheever MA.
    J Immunol; 1990 May 15; 144(10):3659-66. PubMed ID: 2332628
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Eradication of disseminated murine leukemia by treatment with high-dose interleukin 2.
    Thompson JA, Peace DJ, Klarnet JP, Kern DE, Greenberg PD, Cheever MA.
    J Immunol; 1986 Dec 01; 137(11):3675-80. PubMed ID: 3491145
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Antigen-driven T cell clones can proliferate in vivo, eradicate disseminated leukemia, and provide specific immunologic memory.
    Klarnet JP, Matis LA, Kern DE, Mizuno MT, Peace DJ, Thompson JA, Greenberg PD, Cheever MA.
    J Immunol; 1987 Jun 01; 138(11):4012-7. PubMed ID: 3108381
    [Abstract] [Full Text] [Related]

  • 14. Retroviral transduction of protein kinase C-gamma into tumor-specific T cells allows antigen-independent long-term growth in IL-2 with retention of functional specificity in vitro and ability to mediate tumor therapy in vivo.
    Chen W, Schweins E, Chen X, Finn OJ, Cheever MA.
    J Immunol; 1994 Oct 15; 153(8):3630-8. PubMed ID: 7930583
    [Abstract] [Full Text] [Related]

  • 15. Antigen-driven long term-cultured T cells proliferate in vivo, distribute widely, mediate specific tumor therapy, and persist long-term as functional memory T cells.
    Cheever MA, Thompson DB, Klarnet JP, Greenberg PD.
    J Exp Med; 1986 May 01; 163(5):1100-12. PubMed ID: 3084700
    [Abstract] [Full Text] [Related]

  • 16. Therapy of disseminated murine leukemia with cyclophosphamide and immune Lyt-1+,2- T cells. Tumor eradication does not require participation of cytotoxic T cells.
    Greenberg PD, Kern DE, Cheever MA.
    J Exp Med; 1985 May 01; 161(5):1122-34. PubMed ID: 3921652
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The therapeutic efficacy of murine anti-tumor T cells: freshly isolated T cells are more therapeutic than T cells expanded in vitro.
    Evans R, Kamdar SJ, Duffy TM, Krupke DM, Fuller JA, Dudley ME.
    Anticancer Res; 1995 May 01; 15(2):441-7. PubMed ID: 7763019
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.